Search Results 541-550 of 17670 for Prednisone

1. A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010) - Mayo Clinic

   (in dosing exceeding 10 mg daily of prednisone equivalent) or any other form of immunosuppressive therapy within 7 days prior the first dose of study ...

2. Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advance or Metastatic Pancreatic Cancer - Mayo Clinic

   ... prednisone equivalents) or other immunosuppressive medications. NOTE ... prednisone equivalents are permitted in the absence of active autoimmune disease * ...

3. Biomarker-guided CNI substitution in Kidney Transplantation Assessment - Mayo Clinic

   Minimum Prednisone dose of 5mg per day 8. Hepatitis C Virus Ab positive subjects with negative HCV PCR are eligible if they have spontaneously cleared ...

4. A Study to Evaluate the Effectiveness, Safety and Tolerability of PF-06823859 In Adults With Moderate-to-Severe Dermatomyositis - Mayo Clinic

   Intake of greater than 15 mg of prednisone or equivalent per day. Pregnant or breastfeeding females. Fertile men and women who will not comply with the use ...

5. A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants with Moderately to Severely Active Crohn's Disease (CD) - Mayo Clinic

   ... prednisone for 2 weeks if oral or 1 week if IV or ≥ 9 mg/day oral budesonide. Intolerance to CS therapy: History including, but not limited to, Cushing's ...

6. Piperacillin and tazobactam (intravenous route) - Side effects & uses - Mayo Clinic

   Piperacillin and tazobactam combination injection is used to treat bacterial infections in many different parts of the body (eg, stomach or bowel, lungs, skin, ...

7. Rifampin (oral route) - Side effects & dosage - Mayo Clinic

   Prednisone; Raltegravir; Repaglinide; Rofecoxib; Sertraline; Triazolam; Trimetrexate; Valproic Acid; Zaleplon. Other Interactions. Certain medicines should not ...

8. A Study of TAK-981 in Combination with Rituximab in Participants with Relapsed/Refractory (r/r) CD20-positive (CD20+) Non-Hodgkin Lymphoma (NHL) - Mayo Clinic

   ... prednisone (R-CHOP) (or equivalent anti-CD20 containing therapy) and 1 additional line of therapy in the r/r setting. iNHL (including FL of grades 1-3A and ...

9. Butalbital, aspirin, and codeine (oral route) - Mayo Clinic

   Prednisone; Probenecid; Propranolol; Sotalol; St John's Wort; Streptokinase; Tamarind; Temocapril; Tenecteplase; Timolol; Warfarin. Other Interactions. Certain ...

10. A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy - Mayo Clinic

    Patients who have received acute, low-dose (≤ 10 mg/day oral prednisone or equivalent), systemic immunosuppressant medications (e.g., 48 hours of ...